The effective multiplicity of infection for HCMV depends on activity of the cellular 20S proteasome
Katie M. Cataldo, Kathryn L. Roche, Christopher E. Monti, Ranjan K. Dash, Eain A. Murphy, Scott S. Terhune
This study shows that proteasome inhibition reduces HCMV replication by lowering the effective multiplicity of infection, and synergizes with antiviral drugs.
Journal of Virology · Dec 10, 2024Peer-reviewedMicrobiology